ANDA 85959, held by Watson Labs. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 85959 (Chlorpromazine Hydrochloride), held by Watson Labs, was first approved by FDA on Dec 17, 1980, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 17, 1980 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride10MG ยท tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Apr 19, 1988 | Supplement 21Labeling | Approved | None posted |
| Dec 17, 1980 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters